Global Retail Drug Industry Analysis 2012-2017: Industry Trend, Profit, and Forecast Analysis, April 2012
According to this report, the growing aging population and increasing health consciousness among the global populace is likely to drive the Global Retail Drug industry, and the market is forecast to reach an estimated US $1,420 billion in 2017 with a CAGR of 3.6% over the next five years.
The growing aging population and increasing health consciousness among the global populace is likely to drive the Global Retail Drug industry, and the market is forecast to reach an estimated US $1,420 billion in 2017 with a CAGR of 3.6% over the next five years.
Lucintel, a leading global management consulting and market research firm, has analyzed the Global Drug Retail market and presents its findings in -Global Retail Drug Industry Analysis 2012-2017: Industry Trend, Profit, and Forecast Analysis.
The Drug industry consists of pharmacies and drug stores engaged in retailing prescription or nonprescription drugs and medicines, cosmetics, beauty supplies, perfume, optical goods, and health and personal care stores. The industry is highly fragmented and dependent upon macroeconomic factors such as GDP, disposable income, and consumer spending.
The Global Retail Drug market holds immense potential because most of the countries are still under-penetrated. Drug stores are poised for significant growth, as the average age of the consumer is increasing rapidly. An aging population needs increased health care and prescription needs, thus providing a growing customer base for drug stores.
APAC depicts the best growth prospects for retailers in forth coming years with increasing aging population, health consciousness, and consumer demand. Increasing industry share of Asian economies in world trade and rapid industrialization in emerging economies are expected to boost demand in this region. Thus, APAC is expected to grow at a faster pace than other regions.
This study provides an overview of the global retail drug industry. The report tracks market sizing for four geographic regions of the global retail drug industry. The scope of this study is limited to annual trends for the past five years and forecasts for the next five years of this segment.
This comprehensive guide from Lucintel provides readers with valuable information and the tools needed to successfully drive critical business decisions with a thorough understanding of the market’s potential. This report will save Lucintel clients hundreds of hours in personal research time on a global market and it offers significant benefits in expanding business opportunities throughout the global drugs retail industry analysis. In a fast-paced ever-changing world, business leaders need every advantage available to them in a timely manner to drive change in the market and to stay ahead of their competition. This report provides business leaders with a keen advantage in this regard by making them aware of emerging trends and demand requirements on an annual basis.
To make any investment or strategic decision, you need adequate and timely information. This market report fulfills this core need. Some of the features of this market report are:
The growing aging population and increasing health consciousness among the global populace is likely to drive the Global Retail Drug industry, and the market is forecast to reach an estimated US $1,420 billion in 2017 with a CAGR of 3.6% over the next five years.
Lucintel, a leading global management consulting and market research firm, has analyzed the Global Drug Retail market and presents its findings in -Global Retail Drug Industry Analysis 2012-2017: Industry Trend, Profit, and Forecast Analysis.
The Drug industry consists of pharmacies and drug stores engaged in retailing prescription or nonprescription drugs and medicines, cosmetics, beauty supplies, perfume, optical goods, and health and personal care stores. The industry is highly fragmented and dependent upon macroeconomic factors such as GDP, disposable income, and consumer spending.
The Global Retail Drug market holds immense potential because most of the countries are still under-penetrated. Drug stores are poised for significant growth, as the average age of the consumer is increasing rapidly. An aging population needs increased health care and prescription needs, thus providing a growing customer base for drug stores.
APAC depicts the best growth prospects for retailers in forth coming years with increasing aging population, health consciousness, and consumer demand. Increasing industry share of Asian economies in world trade and rapid industrialization in emerging economies are expected to boost demand in this region. Thus, APAC is expected to grow at a faster pace than other regions.
This study provides an overview of the global retail drug industry. The report tracks market sizing for four geographic regions of the global retail drug industry. The scope of this study is limited to annual trends for the past five years and forecasts for the next five years of this segment.
This comprehensive guide from Lucintel provides readers with valuable information and the tools needed to successfully drive critical business decisions with a thorough understanding of the market’s potential. This report will save Lucintel clients hundreds of hours in personal research time on a global market and it offers significant benefits in expanding business opportunities throughout the global drugs retail industry analysis. In a fast-paced ever-changing world, business leaders need every advantage available to them in a timely manner to drive change in the market and to stay ahead of their competition. This report provides business leaders with a keen advantage in this regard by making them aware of emerging trends and demand requirements on an annual basis.
To make any investment or strategic decision, you need adequate and timely information. This market report fulfills this core need. Some of the features of this market report are:
- Industry size estimates in terms of (US $) value by regions
- Global drugs retail industry analysis annual trend (2006-2011) and forecast (2012-2017)
- Porter’s Five Force analysis
- New product launch and merger and acquisition activity in global drugs retail industry analysis
- Quarterly demand trend (Q1 2010-Q4 2011) and forecast analysis (Q1 2012 Q4 2012) for global drugs retail industry analysis
- Gross and net profit trends in the global drugs retail industry analysis
- Cost structure trend in the global as well as regional drugs retail industry analysis
- More than 42 valuable figures/charts and 10 tables are provided in this report
1. EXECUTIVE SUMMARY
2. INDUSTRY DEFINITION AND SCOPE
3. INDUSTRY OVERVIEW
4. GLOBAL MACROECONOMIC OVERVIEW
5. INDUSTRY TRENDS
6. INDUSTRY FORECASTS
7. EMERGING TRENDS
8. CONCLUSIONS
2. INDUSTRY DEFINITION AND SCOPE
3. INDUSTRY OVERVIEW
4. GLOBAL MACROECONOMIC OVERVIEW
5. INDUSTRY TRENDS
6. INDUSTRY FORECASTS
7. EMERGING TRENDS
8. CONCLUSIONS
LIST OF FIGURES
CHAPTER 4. GLOBAL MACROECONOMIC OVERVIEW
Figure 4.1: Global GDP growth rate trend
Figure 4.2: Global inflation rate trend
Figure 4.3: Global population growth rate trend
Figure 4.4: Global unemployment rate trend
Figure 4.5: Regional GDP growth rate trend
Figure 4.6: Regional inflation rate trend
Figure 4.7: Regional population growth rate trend
Figure 4.8: Regional unemployment rate trend
CHAPTER 5. INDUSTRY TRENDS
Figure 5.1: Global drugs retail industry annual trend 2006-11 (US $B)
Figure 5.2: Global drugs retail industry regional trend: 2006-11 (US $B)
Figure 5.3: Global drugs retail industry regional trend: 2006-11 (%)
Figure 5.4: Global drugs retail industry quarterly trend 2010-11 (US $B)
Figure 5.5: Global drugs retail industry profitability trend 2006-11
Figure 5.6: Global drugs retail industry revenue per employee Trend 2006-11
Figure 5.7: Cost structure of global drugs retail industry 2006-11
Figure 5.8: Cost structure in North American drugs retail industry: 2006-11
Figure 5.9: Cost structure in European drugs retail industry: 2006-11
Figure 5.10: Cost structure in Asia Pacific drugs retail industry: 2006-11
Figure 5.11: Top 5 companies vs. drugs retail industry gross profit & net profit analysis: 2011(e)
Figure 5.12: Cash on hand for global drugs retail industry 2006-11 (US $B)
Figure 5.13: Cash on hand for global drugs retail industry 2006-11 (%)
Figure 5.14: Asset for global drugs retail industry 2006-11 (US $B)
Figure 5.15: Assets for global drugs retail industry 2006-11 (%)
Figure 5.16: Debt for global drugs retail industry 2006-11 (US $B)
Figure 5.17: Debt for global drugs retail industry 2006-11 (%)
Figure 5.18: Market shares of top players in global drugs retail industry in 2006
Figure 5.19: Market shares of top players in global drugs retail industry in 2011(e)
Figure 5.20: Global drugs retail industry 2006 market share analysis
Figure 5.21: Global drugs retail industry 2011(e) market share analysis
CHAPTER 6. INDUSTRY FORECASTS
Figure 6.1: Global drugs retail industry annual forecast 2012-17 (US $B)
Figure 6.2: Global drugs retail industry quarterly forecast 2011-12 (US $B)
Figure 6.3: Global GDP growth rate forecast
Figure 6.4: Global inflation rate forecast
Figure 6.5: Global population growth rate forecast
Figure 6.6: Global unemployment rate forecast
Figure 6.7: Regional GDP growth rate forecast
Figure 6.8: Regional inflation rate forecast
Figure 6.9: Regional population growth rate forecast
Figure 6.10: Regional unemployment rate forecast
Figure 6.11: Global drugs retail industry regional forecast 2012-17 (US $B)
Figure 6.12: Global drugs retail industry regional forecast 2012-17 (%)
CHAPTER 7. EMERGING TRENDS
Figure 7.1: Global drugs retail industry opportunity by region
CHAPTER 4. GLOBAL MACROECONOMIC OVERVIEW
Figure 4.1: Global GDP growth rate trend
Figure 4.2: Global inflation rate trend
Figure 4.3: Global population growth rate trend
Figure 4.4: Global unemployment rate trend
Figure 4.5: Regional GDP growth rate trend
Figure 4.6: Regional inflation rate trend
Figure 4.7: Regional population growth rate trend
Figure 4.8: Regional unemployment rate trend
CHAPTER 5. INDUSTRY TRENDS
Figure 5.1: Global drugs retail industry annual trend 2006-11 (US $B)
Figure 5.2: Global drugs retail industry regional trend: 2006-11 (US $B)
Figure 5.3: Global drugs retail industry regional trend: 2006-11 (%)
Figure 5.4: Global drugs retail industry quarterly trend 2010-11 (US $B)
Figure 5.5: Global drugs retail industry profitability trend 2006-11
Figure 5.6: Global drugs retail industry revenue per employee Trend 2006-11
Figure 5.7: Cost structure of global drugs retail industry 2006-11
Figure 5.8: Cost structure in North American drugs retail industry: 2006-11
Figure 5.9: Cost structure in European drugs retail industry: 2006-11
Figure 5.10: Cost structure in Asia Pacific drugs retail industry: 2006-11
Figure 5.11: Top 5 companies vs. drugs retail industry gross profit & net profit analysis: 2011(e)
Figure 5.12: Cash on hand for global drugs retail industry 2006-11 (US $B)
Figure 5.13: Cash on hand for global drugs retail industry 2006-11 (%)
Figure 5.14: Asset for global drugs retail industry 2006-11 (US $B)
Figure 5.15: Assets for global drugs retail industry 2006-11 (%)
Figure 5.16: Debt for global drugs retail industry 2006-11 (US $B)
Figure 5.17: Debt for global drugs retail industry 2006-11 (%)
Figure 5.18: Market shares of top players in global drugs retail industry in 2006
Figure 5.19: Market shares of top players in global drugs retail industry in 2011(e)
Figure 5.20: Global drugs retail industry 2006 market share analysis
Figure 5.21: Global drugs retail industry 2011(e) market share analysis
CHAPTER 6. INDUSTRY FORECASTS
Figure 6.1: Global drugs retail industry annual forecast 2012-17 (US $B)
Figure 6.2: Global drugs retail industry quarterly forecast 2011-12 (US $B)
Figure 6.3: Global GDP growth rate forecast
Figure 6.4: Global inflation rate forecast
Figure 6.5: Global population growth rate forecast
Figure 6.6: Global unemployment rate forecast
Figure 6.7: Regional GDP growth rate forecast
Figure 6.8: Regional inflation rate forecast
Figure 6.9: Regional population growth rate forecast
Figure 6.10: Regional unemployment rate forecast
Figure 6.11: Global drugs retail industry regional forecast 2012-17 (US $B)
Figure 6.12: Global drugs retail industry regional forecast 2012-17 (%)
CHAPTER 7. EMERGING TRENDS
Figure 7.1: Global drugs retail industry opportunity by region
LIST OF TABLES
CHAPTER 3. INDUSTRY OVERVIEW
Table 3.1: Industry parameters of global drugs retail industry
Table 3.2: Relative industry attractiveness by region
CHAPTER 5. INDUSTRY TRENDS
Table 5.1: Regional revenue growth rate
Table 5.2: Percentage change in cost structure
Table 5.3: Percentage change in cash on hand
Table 5.4: Percentage change in total asset
Table 5.5: Percentage change in total debt
Table 5.6: Key companies by revenue growth
Table 5.7: Key companies by revenue decline
CHAPTER 6. INDUSTRY FORECASTS
Table 6.1: Global drugs retail forecast growth rate
CHAPTER 3. INDUSTRY OVERVIEW
Table 3.1: Industry parameters of global drugs retail industry
Table 3.2: Relative industry attractiveness by region
CHAPTER 5. INDUSTRY TRENDS
Table 5.1: Regional revenue growth rate
Table 5.2: Percentage change in cost structure
Table 5.3: Percentage change in cash on hand
Table 5.4: Percentage change in total asset
Table 5.5: Percentage change in total debt
Table 5.6: Key companies by revenue growth
Table 5.7: Key companies by revenue decline
CHAPTER 6. INDUSTRY FORECASTS
Table 6.1: Global drugs retail forecast growth rate
